China has moved to open up its markets to overseas private fund managers by allowing wholly foreign-owned enterprises (WFOEs) and joint ventures to raise capital domestically and invest it in private companies and the stock markets.
KKR will make a partial exit from Chinese car dealership China Greenland Rundong Auto as the company’s founder and president sealed agreements that will see him regain majority control and trigger a mandatory buyout offer.
China Everbright (CEL) and IDG Capital Partners have launched a joint M&A investment fund of at least RMB20 billion ($3 billion) in size that will support the growth of companies in China and overseas.
A subsidiary of Chinese logistics player Shanghai Yupei Group, which is backed by RRJ Capital, The Carlyle Group, and Temasek Holdings, is looking to raise up to HK$3.36 billion ($434 million) through a Hong Kong IPO.
GrowingIO, a Chinese data analysis company founded by executives from LinkedIn’s business analytics division, has raised a $20 million Series A round from Matrix Partners China, NEA and Greylock Partners.
Circle is ready to test its blockchain-based online peer-to-peer payments platform in China, with support from a string of local financial and strategic investors
A fund launched by China Mobile in partnership with the State Development & Investment Corporation (SDIC) has led a $100 million Series D round of funding for online recruitment services provider Liepin.com.
Lightspeed China Partners has reached a final close of $260 million on its third venture fund, substantially above the vehicle's $240 million target.
China Everbright has invested an undisclosed amount in Chinese healthcare conglomerate Neusoft Holdings through its renminbi-denominated mezzanine fund.
Wind turbine manufacturer China Ming Yang Wind Power Group has delisted from the New York Stock Exchange following a take-private involving the company founder and several local private equity investors.
Australia’s Telstra has closed the sale of a 47.7% interest in Chinese auto services company Autohome to Ping An Insurance Group for $1.6 billion.
Chinese private equity firm Ocean Management has made a take-private offer for domestic travel site Qunar that values the US-listed company at about $4.4 billion.
Ant Financial, the online finance affiliate of China's Alibaba Group, has joined a consortium of investors supporting the establishment of Xinmei Mutual Life Insurance Agency.
IDG Capital Partners has led a $60 million financing round for Circle, a US-based financial technology start-up seeking to build a blockchain-supported peer-to-peer payments system business in China.
Chinese state-owned Poly Real Estate Group has set up a private equity fund worth RMB2.5 billion ($380 million) to invest in Chinese leading ride-hailing app Didi Chuxing as part of its latest round.
VC-backed UrWork, a co-working space provider for Chinese start-ups, has completed a pre-Series B round worth RMB300 million ($46 million) from Chinese commercial property developers Yintai Land and Zhongrong International Trust.
VC-backed Chinese vacation-rental website Tujia.com has agreed to take control of its industry peer Mayi.com, which has also received venture investment, for an undisclosed sum.
The mixed ownership model that features in China’s latest push on state-owned enterprise reform sounds exciting in theory but some private equity investors must revise their expectations in practice
Direct secondaries specialist NewQuest Capital Partners has reached a final close of its third fund at the hard cap of $540 million, increasing it from the original hard cap of $520 million in order to accommodate investor demand.
NewMargin Ventures has led a RMB70 million ($10.6 million) Series A round of funding for Flower Plus, a Chinese mobile flower ordering platform.
OrbiMed will consolidate its control of Canada-listed clinical equipment producer Response Biomedical in an C$11.1 million ($8.6 million) take-private deal including participation by Shanghai Runda Medical Technology.
Chinese healthcare-focused GP HighLight Capital has led a RMB50 million ($7.6 million) Series B round for Jun He Tang, a traditional Chinese medicine (TCM) business, followed by existing investor Qiming Venture Partners.
Chinese drug maker Shenzhen Hepalink Pharmaceutical has agreed to commit $60 million to TPG Capital’s latest biotech fund.